The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Fiscal Year 2016: Funds provided under this CFDA provide domestic support via the Epidemiology and Laboratory Capacity (ELC) for Infectious Diseases and the Emerging Infections Program (EIP) Cooperative Agreements. Fiscal year 2016 funds, largely provided via the ELC coag, offered continued support to strengthen the ability of domestic health departments to respond to infectious disease threats. This crucial CDC investment helps local, state, and territorial health departments continue to: ?Build and maintain effective public health workforce for rapid response to infectious disease outbreaks ?Strengthen cross-cutting national surveillance systems ?Boost laboratory infrastructure with the latest diagnostic technologies ?Improve health information systems to efficiently transmit, receive, and analyze infectious disease-related data electronically For any specific ELC or EIP success stories or accomplishments, please contact CDC INFO (800-CDC-INFO) or program via Judy Lavelle (JLavelle@cdc.gov). Fiscal Year 2017: No Current Data Available Fiscal Year 2018: No Current Data Available
Uses and Use Restrictions
Project funds may be used for costs associated with planning, organizing, and the implementation of other program elements to build public health epidemiology, laboratory, and health information systems capacity.
Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual.
Funds may not be used for clinical care.
Eligible applicants include the current ELC and EIP grantees which consists of all U.S.
states, 6 large local health departments (Los Angeles County, Philadelphia, New York City, Chicago, Houston, and the District of Columbia), U.S.
territories (Puerto Rico, Guam, U.S.
Virgin Islands) and other U.S.
affiliates in the Pacific (American Samoa, the Republic of Palau, Federated States of Micronesia, Marshall Islands, Mariana Islands and American Samoa).
State health departments, large local health departments, the District of Columbia, U.S. Territories, and the general public.
Allowable costs will be determined in accordance with OMB Circular No. A-87 for State, Local, and Indian Tribal governments. 2 CFR 200, Subpart E - Cost Principles applies to this program.
Aplication and Award Process
Preapplication coordination is required.
Environmental impact information is not required for this program.
This program is eligible for coverage under E.O.
12372, 'Intergovernmental Review of Federal Programs.' An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applications must be submitted electronically via Grant Solutions.
Applications that are complete and responsive will be evaluated for scientific and technical merit and receive support. CDC will not review incomplete and non-responsive applications. Applications that are complete and responsive will undergo an objective review process, receive a written critique and be scored according to the published review criteria. Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer. Initial award provides funds for the first budget period (usually 12 months) and the NOA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, and special conditions, if any.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Patient Protection and Affordable Care Act (PL 11-148), Title IV, Section 4002 (Prevention and Public Health Fund) for expanded and sustained national investment in prevention and public health programs. This program is funded in part by 2012 Prevention and Public Health Funds (PPHF-2012), Section 301 and 317, 42 U.S.C 241 and 247b; Sections 301 and 317 of the Public Health Service Act (PHS Act), 42 USC, 241 and 247b as amended; and Funding is appropriated under Affordable Care Act (PL 111-148), Title IV, Section 4002 (Prevention and Public Health Fund) , Title IV, Section 4002.
Range of Approval/Disapproval Time
From 90 to 120 days. About 120 days from receipt of application.
Renewals will be based upon availability of funding under the Patient Protection and Affordable Care Act.
Formula and Matching Requirements
This program has no statutory formula. This program has no matching requirements. This program does not have MOE requirements.
Length and Time Phasing of Assistance
Financial assistance is available for a 12-month budget period within project periods ranging from one to five years. Method of awarding/releasing assistance: lump sum.
Post Assistance Requirements
Program reports are not applicable.
No later than 10 days after the end of each calendar quarter, the recipients must submit a calendar quarter cash transaction report (SF-272 or top portion of the SF-425 Financial Report Form) to the Payment Management System (PMS).
The reporting schedule will be based on the requirements listed in the ELC and EIP funding opportunity announcements.
Funded applicants must provide an interim and annual progress report.
Federal Financial Reports (SF 425) and Final Progress Report are due no more than 90 days after the end of the budget period.
All reports must be submitted to the Grants Management Specialist indicated in the NoA.
Federal Financial Reports (SF 425) are due no more than 90 days after the end of the budget period.
Federal Financial Reports and Progress Reports are required, no more than 90 days after the end of the budget/project period.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Records must be available for review or audit by appropriate officials of the Federal agency, pass-through entity, and General Accounting Office (GAO). The grantee is to also ensure that the sub-recipients receiving CDC funds also meet these requirements (if total Federal grant or grants funds received exceed $500,000). The grantee should include this requirement in all sub-recipient contracts.
Financial records, supporting documents, statistical records, and all other records pertinent to the grant program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42.
(Cooperative Agreements) FY 16 $61,134,448; FY 17 est $43,137,343; and FY 18 est $0 - FY2017 and FY2018estimates only. FY2017 awards were not complete at the time of updating this information.
Range and Average of Financial Assistance
No Data Available.
Regulations, Guidelines, and Literature
Regulations governing this program are published under 42 CFR 55b. Guidelines are available. 45 CFR 92, and also HHS Grants Policy Statement at http://www.ahrq.gov/fund/hhspolicy.htm.
Regional or Local Office
Greg J. Jones Scientific and Program Services Branch, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, NE, Mailstop C18, Atlanta, Georgia 30333 Email: GJJ1@cdc.gov Phone: (404) 639-4180 Fax: (404) 639-3106
Criteria for Selecting Proposals
Applications will be evaluated based on: (1) clearly provide a plan that includes quantitative process and outcome measures (2) provide adequate and clear information to enable the reviewer to gain a reasonable understanding of the applicant?s recent and current efforts to address the issues and (3) provide a realistic plan with activities that can be achieved in year one and subsequent years. Other criteria will be listed in the individual funding opportunity announcements.
Gradian Health Systems, which pioneered the CE-marked Universal Anaesthesia Machine to bring general anaesthesia in underserved communities around the world on patients of any age, is a Limited Liability Corporation (LLC) solely owned by a New York City-based private foundation, the Nick Simons Foundation.